Reported signals
thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide
Registration status unknownDrugalgemeen
29,468
reports (FAERS)
58.4%
reported as serious
1,783
fatal reports (6.1%)
0
signals above threshold
2026-07
last updated
Signal ranking · ROR
What stands out in the reports.
No disproportionate signals with sufficient data to plot. This may indicate the substance has too few reports, or that reported effects are in line with background rates.
Interpretation
Summary not yet available — will be auto-generated.
Label versus report
On the label
No signals currently mapped to the label.
Newly reported
No novel signals above threshold.
Recall history · 0 on record
No recalls on record.
Compare within ALGEMEEN
implant
Reports3,932,418
Compare with thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide →
minoxidil foam 5% (womens)
Reports3,436,075
Compare with thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide →
dental implant
Reports3,208,206
Compare with thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide →
Source & citation
HealthProves. thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide — reported signals. Retrieved 2026-07-05. Source: openFDA (FAERS). healthproves.com/thiamine-hydrochloride-riboflavin-5-phosphate-sodium-dexpanthenol-and-niacinamide/
FAERS29,468 records
Retrieved2026-07-05
MethodROR / disproportionality